The AHA, America’s Health Insurance Plans, American Medical Association, American Pharmacists Association, Blue Cross Blue Shield Association and Medical Group Management Association today released a consensus statement outlining their shared commitment to improving the prior authorization process. According to the statement, the organizations will work to reduce the number of health care professionals subject to prior authorization requirements based on their performance, adherence to evidence-based medical practices or participation in a value-based agreement with the insurance provider; regularly review the services and medications that require prior authorization and eliminate requirements for therapies that no longer warrant them; improve channels of communications between insurers, providers and patients to minimize care delays and ensure clarity on requirements, rationale and changes; protect continuity of care for patients who are on an ongoing, active treatment or a stable treatment regimen when there are changes in coverage, insurance provider or prior authorization requirements; accelerate industry adoption of national electronic standards for prior authorization and improve transparency of formulary information and coverage restrictions at the point-of-care. “These principles provide a good starting point for providers and health plans to work together toward continuous improvement in quality of care and health outcomes while reducing unnecessary administrative burden,” said AHA Executive Vice President Tom Nickels.

Related News Articles

Headline
Responding March 15 to a House Committee on Education and the Workforce request for comments on ways to strengthen the Employee Retirement Income Security Act…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…
Headline
The House March 6 voted 339-85 to pass a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains…
Headline
The Justice Department’s Antitrust Division, Federal Trade Commission and Department of Health and Human Services seek public input through May 6 on increasing…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 29 held a hearing on legislative proposals to expand access to treatment for patients with rare…